{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T08:57:35Z","timestamp":1790585855625,"version":"4.1.0"},"reference-count":58,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Oncol. Rev."],"abstract":"<jats:p>NUT carcinoma is a rare and aggressive lung tumor driven by NUTM1 gene rearrangements. It accounts for less than 1% of all lung cancers, with fewer than 100 cases reported worldwide. The disease is often misdiagnosed due to non-specific symptoms and histological overlap with other tumors. This review provides an updated overview of its pathological features, clinical presentation, diagnosis, treatment, and prognosis, aiming to serve as a practical reference for clinicians and pathologists.<\/jats:p>","DOI":"10.3389\/or.2026.1967215","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T08:21:36Z","timestamp":1790583696000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Primary pulmonary NUT carcinoma: pathological features, clinical diagnosis, treatment, and prognosis \u2014 An extended review"],"prefix":"10.3389","volume":"20","author":[{"given":"Shan","family":"Wu","sequence":"first","affiliation":[{"name":"Department of Oncology, Tianjin Union Medical Center, The First Affiliated Hospital of Nankai University, Nankai University","place":["Tianjin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Oncology, Tianjin Union Medical Center, The First Affiliated Hospital of Nankai University, Nankai University","place":["Tianjin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Oncology, Tianjin Union Medical Center, The First Affiliated Hospital of Nankai University, Nankai University","place":["Tianjin, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1097\/00043426-199124000-00011","article-title":"Intrathoracic carcinoma in an 11-year-old girl showing a translocation t(15;19)","volume":"13","author":"Kees","year":"1991","journal-title":"Am J Pediatr Hematol Oncol"},{"key":"B2","first-page":"3327","article-title":"Novel t(15;19)(q15;p13) chromosome abnormality in a thymic carcinoma","volume":"51","author":"Kubonishi","year":"1991","journal-title":"Cancer Res"},{"key":"B3","first-page":"304","article-title":"BRD4-NUT fusion oncogene: a novel mechanism in aggressive carcinoma","volume":"63","author":"French","year":"2003","journal-title":"Cancer Res"},{"key":"B4","volume-title":"WHO Classification of Tumours of the Lung, Pleura, Thymus and Heart","author":"Travis","year":"2015"},{"key":"B5","volume-title":"Thoracic Tumours","year":"2021"},{"key":"B6","doi-asserted-by":"publisher","first-page":"690115","DOI":"10.3389\/fonc.2021.690115","article-title":"Immunotherapy and targeting the tumor microenvironment: current place and new insights in primary pulmonary NUT carcinoma","volume":"11","author":"Li","year":"2021","journal-title":"Front Oncol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1097\/pap.0000000000000439","article-title":"Molecularly defined thoracic neoplasms","volume":"31","author":"Roden","year":"2024","journal-title":"Adv Anat Pathol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/s41571-025-00986-3","article-title":"Hiding in plain sight: NUT carcinoma is an unrecognized subtype of squamous cell carcinoma of the lungs and head and neck","volume":"22","author":"Luo","year":"2025","journal-title":"Nat Rev Clin Oncol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"101068","DOI":"10.1016\/j.xinn.2025.101068","article-title":"International guidelines on the diagnosis and treatment of NUT carcinoma","volume":"7","author":"Zhang","year":"2025","journal-title":"Innovation"},{"key":"B10","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1177\/1066896918796606","article-title":"NUT (nuclear protein in testis) carcinoma: a report of two cases with different histopathologic features","volume":"27","author":"Reddy","year":"2019","journal-title":"Int J Surg Pathol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.14670\/HH-18-905","article-title":"Challenging diagnosis in pulmonary NUT carcinoma: a report of two cases with different histopathologic and molecular features and a novel SPECC1::NUTM1 gene fusion","volume":"40","author":"Xie","year":"2025","journal-title":"Histol Histopathol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s42047-025-00213-4","article-title":"Unveiling the enigmatic primary pulmonary NUT carcinoma with WHSC1L1::NUTM1-rearrangement: a case-based insight and contemporary literature review","volume":"8","author":"Majumdar","year":"2025","journal-title":"Surg Exp Pathol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1053\/j.semdp.2021.06.005","article-title":"NUT carcinoma of the lung","volume":"38","author":"Lantuejoul","year":"2021","journal-title":"Semin Diagn Pathol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"6807","DOI":"10.3390\/curroncol29100536","article-title":"Diagnosis, treatment and prognosis of primary pulmonary NUT carcinoma: a literature review","volume":"29","author":"Yuan","year":"2022","journal-title":"Curr Oncol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"860830","DOI":"10.3389\/fonc.2022.860830","article-title":"NUT carcinoma: clinicopathologic features, molecular genetics and epigenetics","volume":"12","author":"Moreno","year":"2022","journal-title":"Front Oncol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/his.15063","article-title":"NUT carcinoma and thoracic SMARCA4-deficient undifferentiated tumour: facts and controversies","volume":"84","author":"Yoshida","year":"2024","journal-title":"Histopathology"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.3760\/cma.j.cn112151-20230912-00165","article-title":"Primary pulmonary NUT carcinoma: a clinicopathological analysis of seven cases","volume":"52","author":"Zhuang","year":"2023","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"key":"B18","doi-asserted-by":"publisher","first-page":"105928","DOI":"10.1016\/j.labinv.2025.105928","article-title":"Diagnostic pitfalls of pulmonary NUT carcinoma: a clinicopathologic and immunohistochemical analysis of 21 cases","volume":"106","author":"Huang","year":"2026","journal-title":"Lab Invest"},{"key":"B19","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s13256-019-2213-6","article-title":"The first report of molecular characterized BRD4-NUT carcinoma in Brazil: a case report","volume":"13","author":"Oliveira","year":"2019","journal-title":"J Med Case Rep"},{"key":"B20","doi-asserted-by":"publisher","first-page":"381","DOI":"10.3390\/curroncol28060381","article-title":"NUT carcinoma: clinicopathologic features, molecular genetics and epigenetic","volume":"28","author":"French","year":"2021","journal-title":"Curr Oncol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1308432","DOI":"10.3389\/fonc.2023.1308432","article-title":"Primary pulmonary nuclear protein of the testis midline carcinoma: case report and systematic review with pooled analysis","volume":"13","author":"Zhao","year":"2024","journal-title":"Front Oncol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.arbres.2024.09.012","article-title":"Primary pulmonary NUT carcinoma: an aggressive and rare tumor","volume":"61","author":"Martins","year":"2025","journal-title":"Arch Bronconeumol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.3760\/cma.j.cn112152-20250309-00099","article-title":"Clinical analysis of 33 cases of primary pulmonary NUT carcinoma","volume":"47","author":"Jiang","year":"2025","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"B24","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.lungcan.2021.06.008","article-title":"Thoracic NUT carcinoma: common pathological features despite diversity of clinical presentations","volume":"158","author":"Fekkar","year":"2021","journal-title":"Lung Cancer"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e2500526","DOI":"10.1200\/PO-25-00526","article-title":"Presenting features and causes of diagnostic delays: a report from the NUT carcinoma registry","volume":"9","author":"Walton","year":"2025","journal-title":"JCO Precis Oncol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-8909555\/v1","article-title":"Primary pulmonary NUT carcinoma in an older adult with paraneoplastic hypercalcemia: a rare case report","author":"Noor","year":"2026","journal-title":"Res Square"},{"key":"B27","doi-asserted-by":"publisher","first-page":"e82244","DOI":"10.7759\/cureus.82244","article-title":"A rare case of oral-maxillary NUT (nuclear protein in testis) carcinoma with diffuse osseous metastasis and hypercalcemia of malignancy","volume":"17","author":"Abdul","year":"2025","journal-title":"Cureus"},{"key":"B28","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1097\/RCT.0000000000001133","article-title":"NUT midline carcinoma of the lung: computed tomography findings in 10 patients","volume":"45","author":"Chang","year":"2021","journal-title":"J Comput Assist Tomogr"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1083206","DOI":"10.3389\/fmed.2022.1083206","article-title":"Clinical imaging of primary pulmonary nucleoprotein of the testis carcinoma","volume":"9","author":"Huang","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"B30","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1097\/JTO.0000000000000545","article-title":"Primary pulmonary NUT midline carcinoma: clinical, radiographic, and pathologic characterizations","volume":"10","author":"Sholl","year":"2025","journal-title":"J Thorac Oncol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1097\/RLU.0000000000005872","article-title":"18F-FDG PET\/CT in NUT carcinoma of the thorax","volume":"50","author":"Schlemmer","year":"2025","journal-title":"Clin Nucl Med"},{"key":"B32","doi-asserted-by":"publisher","first-page":"898","DOI":"10.5858\/arpa.2023-0178-oa","article-title":"Nuclear protein in testis (NUT) carcinoma: a comprehensive immunohistochemical analysis of 57 cases with consideration of interpretation and pitfall recognition","volume":"148","author":"Farooq","year":"2024","journal-title":"Arch Pathol Lab Med"},{"key":"B33","doi-asserted-by":"publisher","first-page":"865","DOI":"10.4103\/ijpm.ijpm_493_24","article-title":"p63-negative thoracic NUT carcinoma: a potential diagnostic pitfall","volume":"68","author":"Anila","year":"2025","journal-title":"Indian J Pathol Microbiol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13000-024-01448-7","article-title":"Neuroendocrine and squamous cell phenotypes of NUT carcinoma are potential diagnostic pitfalls that discriminating it from mimickers, such as small cell and squamous cell carcinoma","volume":"19","author":"Ninomiya","year":"2024","journal-title":"Diagn Pathol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"W391","DOI":"10.2214\/AJR.13.12401","article-title":"Demystifying NUT midline carcinoma: radiologic and pathologic correlations of an aggressive malignancy","volume":"203","author":"Bair","year":"2014","journal-title":"AJR Am J Roentgenol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"3922","DOI":"10.1158\/1078-0432.CCR-25-1071","article-title":"Molecular characterization of NUT carcinoma: a report from the NUT carcinoma registry","volume":"31","author":"Kim","year":"2025","journal-title":"Clin Cancer Res"},{"key":"B37","doi-asserted-by":"publisher","first-page":"S1065","DOI":"10.1016\/j.jtho.2021.08.431","article-title":"P38.01 p40 and p63 immunohistochemistry in the diagnostic consideration of NUT carcinoma in the lung","volume":"16","author":"Roe","year":"2021","journal-title":"J Thorac Oncol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s12885-025-13593-3","article-title":"Pulmonary nuclear protein in testis (NUT) carcinoma: clinical, molecular characteristics, and treatment strategies","volume":"25","author":"Qu","year":"2025","journal-title":"BMC Cancer"},{"key":"B39","doi-asserted-by":"publisher","first-page":"107496","DOI":"10.1016\/j.lungcan.2024.107496","article-title":"Clinical management of NUT carcinoma (NC) in Germany: analysis of survival, therapy response, tumor markers and tumor genome sequencing in 35 adult patients","volume":"189","author":"Kloker","year":"2024","journal-title":"Lung Cancer"},{"key":"B40","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.jtho.2023.12.022","article-title":"Initial chemotherapy for locally advanced and metastatic NUT carcinoma","volume":"19","author":"Luo","year":"2024","journal-title":"J Thorac Oncol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1097\/CAD.0000000000001741","article-title":"Early sensitivity and rapid resistance to drug therapy in primary pulmonary nuclear protein in testis carcinoma","volume":"36","author":"Ma","year":"2025","journal-title":"Anticancer Drugs"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1497124","DOI":"10.3389\/fimmu.2025.1497124","article-title":"Pulmonary NUT carcinoma, an elusive and refractory entity, shows transient response to chemotherapeutics and PD-1 inhibitor: a case report and literature review","volume":"16","author":"Yang","year":"2025","journal-title":"Front Immunol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"5773","DOI":"10.1158\/1078-0432.CCR-12-1153","article-title":"Clinicopathologic features and long-term outcomes of NUT midline carcinoma","volume":"18","author":"Bauer","year":"2012","journal-title":"Clin Cancer Res"},{"key":"B44","doi-asserted-by":"publisher","first-page":"pkz094","DOI":"10.1093\/jncics\/pkz094","article-title":"An anatomical site and genetic-based prognostic model for patients with nuclear protein in testis (NUT) midline carcinoma: analysis of 124 patients","volume":"4","author":"Chau","year":"2019","journal-title":"JNCI Cancer Spectr"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1827995","DOI":"10.3389\/fonc.2026.1827995","article-title":"Primary pulmonary NUT carcinoma with NSD3\u2013NUTM1 fusion treated with dose-escalated adaptive radiotherapy and multimodal therapy: case report","volume":"16","author":"Umay","year":"2026","journal-title":"Front Oncol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s11684-025-1145-3","article-title":"Anti-angiogenic therapy as a beacon of hope in the battle against pulmonary NUT midline carcinoma","volume":"19","author":"Tian","year":"2025","journal-title":"Front Med"},{"key":"B47","doi-asserted-by":"publisher","first-page":"6361","DOI":"10.1007\/s00432-023-04621-5","article-title":"Clinical and molecular features of pulmonary NUT carcinoma characterizes diverse responses to immunotherapy, with a pathologic complete response case","volume":"149","author":"Chen","year":"2023","journal-title":"J Cancer Res Clin Oncol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"690115","DOI":"10.3389\/fonc.2021.690115","article-title":"Immunotherapy and targeting the tumor microenvironment: current place and new insights in primary pulmonary NUT carcinoma","volume":"11","author":"Li","year":"2021","journal-title":"Front Oncol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"8586","DOI":"10.1200\/jco.2025.43.16_suppl.8586","article-title":"Efficacy profile of pembrolizumab for primary pulmonary NUT carcinoma: a systematic review and meta-analysis","volume":"43","author":"Alluri","year":"2025","journal-title":"J Clin Oncol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"860830","DOI":"10.3389\/fonc.2022.860830","article-title":"NUT carcinoma: clinicopathologic features, molecular genetics, and epigenetics","volume":"28","author":"Moreno","year":"2021","journal-title":"Curr Oncol"},{"key":"B51","article-title":"NHWD-870 receives breakthrough therapy designation from China's NMPA for rare NUT carcinoma","year":"2025","journal-title":"trial.medpath.com"},{"key":"B52","doi-asserted-by":"publisher","first-page":"100885","DOI":"10.1016\/j.jtocrr.2025.100885","article-title":"Complete response to BET inhibitor in primary pulmonary NUT carcinoma with single-cell sequencing-based analysis: a case report","volume":"6","author":"Ye","year":"2025","journal-title":"JTO Clin Res Rep"},{"key":"B53","volume-title":"FDA Grants Zenith's ZEN-3694 Fast Track Status","year":"2025"},{"key":"B54","volume-title":"Zenith Epigenetics Announces FDA Orphan Drug Designation for ZEN-3694 for Treatment of NUT Carcinoma","year":"2025"},{"key":"B55","unstructured":"NCT05372640. A phase 1 study of BET bromodomain inhibitor ZEN003694 in combination with the CDK4\/6 inhibitor abemaciclib in patients with NUT carcinoma, breast cancer and other solid tumors"},{"key":"B56","unstructured":"NCT05019716. Testing the safety and efficacy of the addition of a new anti-cancer drug, ZEN003694, to chemotherapy treatment (cisplatin and etoposide or carboplatin and paclitaxel) for adult and pediatric patients (12-17 years) with NUT carcinoma"},{"key":"B57","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1002\/pbc.25350","article-title":"Histone deacetylase inhibitor for NUT midline carcinoma","volume":"62","author":"Maher","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.21037\/tlcr-24-259","article-title":"Transcriptomic profiling of a late recurrent nuclear protein in testis carcinoma of the lung 14 years after the initial operation: a case report","volume":"13","author":"Kato","year":"2024","journal-title":"Transl Lung Cancer Res"}],"container-title":["Oncology Reviews"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/or.2026.1967215\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T08:21:41Z","timestamp":1790583701000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/or.2026.1967215\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,28]]},"references-count":58,"alternative-id":["10.3389\/or.2026.1967215"],"URL":"https:\/\/doi.org\/10.3389\/or.2026.1967215","relation":{},"ISSN":["1970-5557"],"issn-type":[{"value":"1970-5557","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,28]]},"article-number":"1967215"}}